Aesthetic medical device company Cartessa Aesthetics reported on Monday that it has entered into an exclusive distribution agreement with Aesthetics Biomedical for the latter's Vivace RF Microneedling device along the US East Coast.
Launched in 2016, Aesthetics Biomedical's Vivace Fractional Microneedling device combines the benefits of microneedling with the skin-tightening effects of radiofrequency (RF) and does so at highly precise and deep layers of the skin. The robotic precision minimizes discomfort, eliminates downtime and creates an ideal skin canvas to administer post-treatment serums.
Since Cartessa's launch in early 2017, the Vivace has been a standout in the company's product portfolio.
With demand for microneedling continuing to grow, the sales of the Vivace device grew nearly 300 percent in 2017 and Vivace treatments were up 60% in Q4 alone. When compared with competitive devices, Vivace is the most powerful and technically comprehensive RF microneedling device available.
IQVIA Launches RIM Smart Regulatory Information Management System
Novus Therapeutics Doses First Subjects in Phase 1 Pharmacodynamics Study of OP0201
FDB Releases Patient-Specific Medication Decision Support Solution for Use in EHR Workflow
GlobalMed Technologies collaborates with DermaConcepts
Biogennix Names Baizer as Chief Financial Officer
Icon Launches New Drug Safety Reporting Solution that Ensures Compliance through Automation
VentureMed Group names new president and chief executive officer
Antibe Therapeutics Enters CDN 5m Bought Deal Offering
Newron Pharmaceuticals' STARS clinical study completes patient enrolment
Senseonics Extends Distribution Agreement with Roche Diabetes Care
Senseonics Extends Distribution Agreement with Roche Diabetes Care